[Antianemic effect of ampevit and orkomin].
The antianemic action of ampevit and orkomin developed at the Laboratory of Experimental Therapy, Institute of Gerontology, Academy of Medical Sciences of the USSR was studied in experiments on young and old animals. It has been established that repeated administration of the drugs increases the reticulocyte count in both groups of animals. Ampevit diminishes severity of posthemorrhagic anemia. Both drugs promote more rapid recovery of hemoglobin content and red cell count in old animals after blood loss. The data obtained were supported by clinical trials of the drugs which have been recommended for combined treatment of posthemorrhagic anemias and other conditions accompanied by weakened function of the growing red fiber of the bone marrow seen also in people of old and senile age.
D000367:Age Factors; D000596:Amino Acids / Q000627:therapeutic use*; D000740:Anemia / Q000188:drug therapy*; D000818:Animals; D001769:Blood / Q000187:drug effects; D004338:Drug Combinations; D004353:Drug Evaluation, Preclinical; D005260:Female; D006470:Hemorrhage / Q000188:drug therapy; D008297:Male; D008903:Minerals / Q000627:therapeutic use*; D011492:Protein Hydrolysates / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats; D013997:Time Factors; D014131:Trace Elements / Q000627:therapeutic use*; D014803:Vitamin B Complex / Q000627:therapeutic use*
D000596:Amino Acids; D004338:Drug Combinations; D008903:Minerals; D011492:Protein Hydrolysates; D014131:Trace Elements; D014803:Vitamin B Complex
Antianemicheskiĭ éffekt ampevita i orkomina.